HTC
CLVS

Hershey Trust Company’s Clovis Oncology, Inc. CLVS Stock Holding History

Hershey Trust Company’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,763
Closed -$446K – 18
2017
Q2 		$446K Buy
+4,763
New +$291K 0.01% 9
2015
Q3 		– Sell
-6,335
Closed -$557K – 16
2015
Q2 		$557K Buy
+6,335
New +$542K 0.01% 8
2015
Q1 		– Sell
-13,179
Closed -$738K – 17
2014
Q4 		$738K Hold
13,179
– – 0.01% 5
2014
Q3 		$598K Hold
13,179
– – 0.01% 4
2014
Q2 		$546K Buy
+13,179
New +$679K 0.01% 4
2013
Q3 		– Sell
-10,796
Closed -$723K – 72
2013
Q2 		$723K Buy
+10,796
New +$485K 0.01% 90

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hershey Trust Company's CLVS Position: Q3 2017 in Review

Hershey Trust Company sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 4,763 shares — an estimated $446K sold.

Hershey Trust Company first reported a position in CLVS in Q2 2013 and held it in 6 quarters. The position peaked at $738K in Q4 2014. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Hershey Trust Company reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Hershey Trust Company sold 4,763 Clovis Oncology, Inc. shares in Q3 2017, an estimated $446K.
  • Hershey Trust Company first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 6 quarters.
  • Hershey Trust Company's Clovis Oncology, Inc. position peaked at $738K in Q4 2014.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Hershey Trust Company's 13F filing for Q3 2017, filed 24 Oct 2017.